This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Simvastatin addition to improve symptoms, cognitio...
Clinical trial

Simvastatin addition to improve symptoms, cognition and metabolic syndrome in patients with recent-onset schizophrenia.

Read time: 1 mins
Last updated:5th Jun 2013
The primary objective of this trial is to investigate the proposed beneficial effect of simvastatin as compared to placebo when given in addition to antipsychotic medication on symptom severity as measured through Positive and Negative Syndrome Scale (PANSS).
Category Value
Study start date 2013-06-05

View full details